Quality of life and psychological well-being in Spanish long-term survivors of Hodgkin's disease: Results of a controlled pilot study

Annals of Hematology

Volumn 82, Issue 1, 2003, Pages 14-18

  Gil Fernandez J J ^a,c   Ramos, C ^b   Tamayo, A T ^a   Tomas J F ^a   Figuera, A ^a   Arranz, R ^a   Martinez Chamorro C ^a   Fernandez Ranada J M ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c NONE   (Spain)

Author keywords

Hodgkin's disease; Psychological; Quality of life

Indexed keywords

BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ANXIETY; ARTICLE; CANCER RESEARCH; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DEPRESSION; DISEASE ACTIVITY; DYSPNEA; ECONOMIC ASPECT; EUROPE; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEALTH CARE ORGANIZATION; HEALTH STATUS; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; MALE; MEDICAL CARE; MENTAL HEALTH; PATIENT SELECTION; PHYSICAL CAPACITY; PILOT STUDY; POSTAL MAIL; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; SECOND CANCER; SOCIAL ASPECT; SOCIOECONOMICS; SPAIN; SURVIVAL TIME; SYMPTOMATOLOGY; WELLBEING; CASE CONTROL STUDY; MIDDLE AGED; SURVIVOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANXIETY; CASE-CONTROL STUDIES; DEPRESSION; FEMALE; HODGKIN DISEASE; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; PILOT PROJECTS; QUALITY OF LIFE; QUESTIONNAIRES; SPAIN; SURVIVORS;

EID: 0037675079     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-002-0582-0     Document Type: Article

References (30)

1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al. (1993) The European Organization for Research and Treatment of Cancer QLQ3O: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376
2. Aisenberg AC (1999) Problems in Hodgkin's disease management. Blood 93:761-779
3. Arranz R, Gil-Fernández JJ, Muñoz E, Acevedo A, Sobrino MP, Fernández-Rañada JM (1998) Evolución de 70 pacientes diagnosticados de enfermedad de Hodgkin tras tratamiento de primera línea y de rescate: experiencia de un centro. Sangre (Barc) 43:179-184
4. Arranz R, Tomás JF, Gil-Fernández JJ, Martínez-Chamorro C, Granados E, Alegre A, Figuera A, Camara R, Vázquez L, Fernández-Rañada JM (1998) Autologous stem cell transplantation (ASCT) for poor prognostic Hodgkin's disease: comparative results with two CBV regimens and importance of disease status at transplant. Bone Marrow Transplant 21:779-786
5. Bierman PJ, Anderson JR, Freeman MB, Vose JM, Kessinger A, Bishop MR, Armitage JO (1996) High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy. Ann Oncol 7:151-156
6. Bonadonna G, Valagussa P, Santoro A (1986) Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease: a report of 8-year results. Ann Intern Med 104:739-746
7. Canellos GP, Anderson JR, Propert KJ, Nissen N, Cooper MR, Henderson ES, Green MR, Gottlieb A, Peterson BA (1992) Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD or MOPP alternating with ABVD. N Engl J Med 327:1478-1484
8. Carroll BT, Kathol RG, Noyes R Jr, Wald TG, Clamon GH (1993) Screening for depression and anxiety in cancer patients using the Hospital Anxiety and Depression Scale. Gen Hosp Psychiatry 15:69-74
9. Cella DF, Tross S (1986) Psychological adjustment to survival from Hodgkin's disease. J Consult Clin Psychol 54:616-622
10. DeVita VT Jr, Simon RM, Hubbard SM, Young RC, Berard CW, Moxley JH 3rd, Frei E 3rd, Carbone PP, Canellos GP (1980) Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. Ann Intern Med 92:587-595
11. Diehl V (ed) (1996) Hodgkin's disease. Baillieres Clin Haematol 9:543-551, 573-593
12. Hodgkin T (1832) On some morbid appearances of the absorbent glands and spleen. Med Chir Trans 17:68-144
13. Hancock SL, Hoppe RT (1996) Long-term complications of treatment and causes of mortality after Hodgkin's disease. Semin Radiat Oncol 6:225-242
14. Hoppe RT (1997) Hodgkin's disease: complications of therapy and excess mortality. Ann Oncol 8:115-118
15. Joly F, Henry-Amar M, Arveux P, Reman O, Tanguy A, Peny AM, Lebailly P, Mace-Lesec'h J, Vie B, Genot JY, Busson A, Troussard X, Leporrier M (1996) Late psychosocial sequelae in Hodgkin's disease survivors: a French population-based case-control study. J Clin Oncol 14:2444-2453
16. Kornblith AB, Anderson J, Cella DF, Tross S, Zuckerman E, Cherin E, Henderson ES, Weiss RB, Cooper MR, Silver RT, et al. (1990) Quality of life assessment of Hodgkin's disease survivors: a model for cooperative clinical trials. Oncology (Huntingt) 4:93-101
17. Linch DC, Winfield D, Goldstone AH, Moir D, Hancock B, McMillan A, Chopra R, Milligan D, Hudson GV (1993) Dose intensification with autologous bone marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomized trial. Lancet 341:1051-1054
18. Loge JH, Abrahamsen AF, Ekeberg O, Hannisdal E, Kaasa S (1997) Psychological distress after cancer cure: a survey of 459 Hodgkin's disease survivors. Br J Cancer 76:791-796
19. Longo DL, Young RC, Wesley M, Hubbard SM, Duffey PL, Jaffe ES, DeVita VT Jr (1986) Twenty years of MOPP therapy for Hodgkin's disease. J Clin Oncol 4:1295-1306
20. Mauch PM (1994) Controversies in the management of early stage Hodgkin's disease. Blood 83:318-329
21. Norum J, Wist E (1996) Psychological distress in survivors of Hodgkin's disease. Support Care Cancer 4:191-195
22. Rosenberg SA (1996) The management of Hodgkin's disease: half a century of change. Ann Oncol 7:555-560
23. Sans-Sabrafén J (1997) Pasado, presente y futuro de la enfermedad de Hodgkin. Haematologica 82 [Suppl 1]:51-63
24. Sureda A, Arranz R, Iriondo A, Carreras E, Lahuerta JJ, Garcia-Conde J, Jarque I, Caballero MD, Ferra C, Lopez A, Garcia-Larana J, Cabrera R, Carrera D, Ruiz-Romero MD, Leon A, Rifon J, Diaz-Mediavilla J, Mataix R, Morey M, Moraleda JM, Altes A, Lopez-Guillermo A, de la Serna J, Fernandez-Rañada JM, Sierra J, Conde E (2001) Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Espanol de Linfomas/Transplante Autologo de Medula Osea Spanish Cooperative Group. J Clin Oncol 19:1395-1404
25. Swerdlow AJ, Barber JA, Horwich A, Cunningham D, Milan S, Omar RZ (1997) Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital. Br J Cancer 75:116-123
26. Van Tulder MW, Aaronson NK, BruningEF (1994) The quality of life of long term survivors of Hodgkin's disease. Ann Oncol 5:153-158
27. Viviani S, Bonadonna G, Santoro A, Bonfante V, Zanini M, Devizzi L, Soncini F, Valagussa P (1996). Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten year result. J Clin Oncol 14:1421-1430
28. Yellen SB, Celia DF, Bonomi A (1993) Quality of life in people with Hodgkin's disease. Oncology (Huntingt) 7:41-52
29. Yuen AR, Rosenberg SA, Hoppe RT, Halpern JD, Horning SJ (1997) Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease. Blood 89:814-822
30. Zigmond AS, Snaith RE (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361-370